• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hospital-acquired Clostridium difficile-associated disease in the intensive care unit

sharon sanders

Editor-in-Chief & President
<table border="0" cellpadding="0" cellspacing="0" width="100%"><tbody><tr valign="bottom"><td align="left">Research article
</td><td align="right"><!-- <rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"> <cc:Work rdf:about="http://www.biomedcentral.com/1471-2334/7/42"> <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/> </cc:Work> <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/"> <cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/> <cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/> <cc:requires rdf:resource="http://web.resource.org/cc/Notice"/> <cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/> <cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/> </cc:License> <item rdf:about="http://www.biomedcentral.com/1471-2334/7/42"> <title>Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome</title> <dc:title>Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome</dc:title> <dc:creator>Marra, Alexandre R.</dc:creator> <dc:creator>Edmond, Michael B.</dc:creator> <dc:creator>Wenzel, Richard P.</dc:creator> <dc:creator>Bearman, Gonzalo M. L.</dc:creator> <dc:identifier>info:doi/10.1186/1471-2334-7-42</dc:identifier> <dc:source>BMC Infectious Diseases 2007, 7:42</dc:source> <dc:date>2007-05-21</dc:date>
BMC Infectious Diseases</prism:publicationName>
2007-05-21</prism:publicationDate>
7</prism:volume>
1</prism:number>
Research article</prism:section>
42</prism:startingPage> </item> </rdf:RDF> -->.</td> </tr> </tbody></table>Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome
Alexandre R. Marra , Michael B. Edmond , Richard P. Wenzel and Gonzalo M. L. Bearman

BMC Infectious Diseases 2007, 7:42 doi:10.1186/1471-2334-7-42

<table class="smalltext" cellpadding="0" cellspacing="0"><tbody><tr> <td>Published</td> <td width="25"> </td> <td>21 May 2007</td> </tr> </tbody></table>
Abstract (provisional)

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

Background
Clostridium difficile-associated disease (CDAD) is a serious nosocomial infection, however few studies have assessed CDAD outcome in the intensive care unit (ICU). We evaluated the epidemiology, clinical course and outcome of hospital-acquired CDAD in the critical care setting.
Methods
We performed a historical cohort study on 58 adults with a positive C. difficile cytotoxin assay result occurring in intensive care units.
Results
Sixty-two percent of patients had concurrent infections, 50% of which were bloodstream infections. The most frequently prescribed antimicrobials prior to CDAD were anti-anaerobic agents (60.3%). Septic shock occurred in 32.8% of CDAD patients. The in-hospital mortality was 27.6%. Univariate analysis revealed that SOFA score, at least one organ failure and age were predictors of mortality. Charlson score greater than or equal to 3, gender, concurrent infection, and number of days with diarrhea before a positive C. difficile toxin assay were not significant predictors of mortality on univariate analysis. Independent predictors for death were SOFA score at infection onset (per 1-point increment, OR 1.40; CI95 1.13-1.75) and age (per 1-year increment, OR 1.10; CI95 1.02-1.19).
Conclusions
In ICU patients with CDAD, advanced age and increased severity of illness at the onset of infection, as measured by the SOFA score, are independent predictors of death.


http://www.biomedcentral.com/content/pdf/1471-2334-7-42.pdf
 
Back
Top